MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2021-22)
- Udyam number
- UDYAM-TS-09-0015559
Sahithi Pharma Private Limited
Sahithi Pharma Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹34.27 Cr
▲ 67% YoY
Net profit · FY 2025
₹97.97 Lakh
Net margin 2.9%
EBITDA · FY 2025
₹5.78 Cr
EBITDA margin 16.9%
Authorised capital
₹11.5 Cr
Registered with MCA
Paid-up capital
₹11.5 Cr
Issued & subscribed
Open charges
₹21.7 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
About Sahithi Pharma Private Limited
Data last updated:
Sahithi Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the solvent and oil extraction tech segment of the chemicals and materials sector. It was incorporated on 11 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2021PTC151302. Its GSTIN is 37ABGCS0459P1ZP (Andhra Pradesh).
The company has an authorised share capital of ₹11.5 Cr and a paid-up capital of ₹11.5 Cr. It is led by directors including Sridhar Raju Gadiraju and Nagaraju Nadimpally.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.27 Cr, a growth of 67% compared to the previous year. For the same year it recorded a net profit of ₹97.97 Lakh (net margin 2.9%) and EBITDA of ₹5.78 Cr (EBITDA margin 16.9%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
As per MCA filings, the company has open charges of ₹21.7 Cr on record.
Sahithi Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0015559). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24110TG2021PTC151302
Registration Number 151302
Incorporation Date 11 May 2021
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-09-0015559
Key People
Sridhar Raju Gadiraju Director Nagaraju Nadimpally Director Anjaneya Raju Penmetsa Director Recognitions & Rankings of Sahithi Pharma
Contact details
Sahithi Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No 301 Plot No 255, Sneha Sadan Nallagandla Serilingampally Mandal, Hyderabad, Telangana, India – 500019
- IndustryChemicals and Materials, Solvent & Oil Extraction Tech
To see the full contact details of Sahithi Pharma Private Limited, buy the company report.
Comprehensive company report
Sahithi Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sahithi Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sahithi Pharma Private Limited, buy the company report.
Financials of Sahithi Pharma Private Limited
FY 2025 filings availableSahithi Pharma Private Limited reported revenue of ₹34.27 Cr (up 67% YoY) for FY 2025.
Revenue · FY 2025
₹34.27 Cr ▲ 67%
Net profit · FY 2025
₹97.97 Lakh margin 2.9%
EBITDA · FY 2025
₹5.78 Cr margin 16.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▲ 272%
3 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 67% growth in the latest year. EBITDA rose 272% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.78 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹97.97 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 16.9% | |||
| Net Profit Margin | 2.9% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sahithi Pharma Private Limited, buy the company report.
Board of directors of Sahithi Pharma Private Limited
Sahithi Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sridhar Raju Gadiraju | Director | 11 May 2021 | 5 Years 5 Months | Current |
| Nagaraju Nadimpally | Director | 11 May 2021 | 5 Years 5 Months | Current |
| Anjaneya Raju Penmetsa Also directs: Sahasra Pharma Chem Private Limited | Director | 11 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Sahithi Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Belchem Industries (India) Pvt Ltd | ₹34.64 Cr (FY 2024) | 8.0% | Thane, Maharashtra, India | |||
| Shree Chemopharma Ankleshwar Private Limited | ₹34.53 Cr (FY 2025) | -26.0% | Bharuch, Gujarat, India | |||
| Kriyansh Industries Private Limited | ₹34.33 Cr (FY 2025) | 12.0% | Ludhiana, Punjab, India | |||
| Ecowalk Impex Private Limited | ₹34.27 Cr (FY 2024) | 3.0% | Bahadurgarh, Haryana, India | |||
| Sahithi Pharma Private Limitedthis company | ₹34.27 Cr (FY 2025) | ₹97.97 Lakh | 2.9% | 67.0% | Hyderabad, Telangana, India | |
| Sriraam Chemicals Private Limited | ₹34.08 Cr (FY 2025) | 17.0% | Thoothukudi, Tamil Nadu, India | |||
| Tangent Science Private Limited | ₹33.89 Cr (FY 2025) | 92.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sahithi Pharma Private Limited, buy the company report.
Auditor
Sahithi Pharma Private Limited is audited by PENDYALA AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PENDYALA AND CO | FY 2023 | 02632s |
Shareholding
The shareholding of Sahithi Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sahithi Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹21.7 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101163818 | Axis Bank Limited | ₹45 Lakh | Open | |
| 22 Sep 2021 | 100486358 | Others | ₹12.75 Cr | Open | |
| 22 Sep 2021 | 100486423 | Others | ₹8.5 Cr | Open |
To see the full charge records of Sahithi Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Sahithi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sahithi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Sahithi Pharma Private Limited has 2 active EPFO establishments as of Mar 29, 2024.
Active EPFO establishments
2
GST
Sahithi Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABGCS0459P1ZP | Andhra Pradesh | Active | 24 May 2021 |
To see the full GST registrations and return filing status of Sahithi Pharma Private Limited, buy the company report.
Recent activity
Sahithi Pharma Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anjaneya Raju Penmetsa was appointed as Director on 11 May 2021.
AGM
Sahithi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.45 Cr with Charge ID 101163818 was registered on 30 Sep 2025.
Filing
Sahithi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 8.50 Cr registered on 22 Sep 2021 with Charge ID 100486423 was modified on 29 Apr 2023.
Charges
A charge with Others amounted to Rs. 12.75 Cr with Charge ID 100486358 was registered on 22 Sep 2021.
Charges
A charge with Others amounted to Rs. 8.50 Cr with Charge ID 100486423 was registered on 22 Sep 2021.
Appointed
Anjaneya Raju Penmetsa was appointed as Director.
Appointed
Nagaraju Nadimpally was appointed as Director.
Appointed
Sridhar Raju Gadiraju was appointed as Director.
Incorporation
11 May 2021
Sahithi Pharma Private Limited was registered on 11 May 2021 with Roc Hyderabad & aged 5 years 5 months as per MCA records.
Frequently asked questions
Sahithi Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in solvent and oil extraction tech, within the chemicals and materials industry. It was incorporated on 11 May 2021 (5+ years old) and is registered under CIN U24110TG2021PTC151302.
Sahithi Pharma has 3 current directors:
- Sridhar Raju Gadiraju - Director
- Nagaraju Nadimpally - Director
- Anjaneya Raju Penmetsa - Director
The latest financial statements of Sahithi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sahithi Pharma is 37ABGCS0459P1ZP, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Sahithi Pharma is U24110TG2021PTC151302. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sahithi Pharma was incorporated on 11 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Sahithi Pharma by revenue are Belchem Industries (India) Pvt Ltd, Shree Chemopharma Ankleshwar Private Limited, Kriyansh Industries Private Limited, Ecowalk Impex Private Limited, Sriraam Chemicals Private Limited and 1 more, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anjaneya Raju Penmetsa was appointed as Director on 11 May 2021. Nagaraju Nadimpally was appointed as Director on 11 May 2021. Sridhar Raju Gadiraju was appointed as Director on 11 May 2021.
Yes, Sahithi Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-09-0015559).
The registered office of Sahithi Pharma is at Flat No 301 Plot No 255, Sneha Sadan Nallagandla Serilingampally Mandal, Hyderabad, Telangana, India – 500019.
Sahithi Pharma operates in the chemicals and materials industry, in the solvent and oil extraction tech segment.